The report provides a detailed analysis essential for determining the production cost of Rituximab. It encompasses all
critical aspects, including in-depth insights into manufacturing expenses, facility setup costs, and both capital and
operational expenditures. The study also explores the core financial and technical requirements for establishing and
running a Rituximab production facility, covering elements such as production processes, raw material inputs,
utility usage, infrastructure development, machinery and technology, workforce needs, packaging, logistics, and other
key operational factors.